VCBeat Health Contact Us
Home Breakthrough! AcoMed's Cardiac Pulsed Field Ablation System Receives NMPA Approval for Market Launch

Breakthrough! AcoMed's Cardiac Pulsed Field Ablation System Receives NMPA Approval for Market Launch

Apr 30, 2025 19:21 CST Updated 19:21
AccuPulse

Developer of products in the field of cardiac electrophysiology


Heart Future

April 29, 2025,AccuPulse Medical Technology Co.Ltd's self-developedPFA Cardiac Pulse Ablation SystemOfficially approved by the China National Medical Products Administration (NMPA) and launched in China!

The systemByAccuPulse®Single-Use Cardiac Pulse Electric Field Ablation CatheterAndAccuBlator®Multi-Channel Pulsed Electric Field Ablation SystemComposition`, providing patients with tachyarrhythmia a simple, effective, and safer treatment option.`
图片
▲Image source: Official website of the National Medical Products Administration
The AccuPulse approved this time®Cardiac Pulse Ablation System,Throughout China8 Research Centers, 17 Electrophysiology ExpertsVerification, achieving a 100% immediate success rate during the operation.。

# AccuPulse®

Single-Use Cardiac Pulsed Field Ablation Catheter


图片

AccuPulse's newly approved disposable cardiac pulsed field ablation catheter has overcome the challenges of stability and anatomical adaptability in PFA ablation catheters, providing a precise and reliable solution for pulmonary vein isolation (PVI).

AccuPulse®The AccuPulse circular pulse ablation catheter features a unique 7.5F adjustable loop diameter design.，Flexible pulmonary vein ablation for different anatomical structures,Intelligent docking prompts and flexible electrode selectionAllow the surgeon to have full control and achieve precise pulse ablation!

  • Finer:7.5F ultra-fine catheter, reducing tissue damage;

  • More Stable:Intelligent docking prompts for more precise operation;

  • More flexible:Adjustable loop diameter (15-20mm or 20-25mm) to accommodate different clinical choices;

  • Safer:Local anesthesia is applicable, reducing the risk of complications.

# AccuBlator®

Multi-channel Pulsed Electric Field Ablation System


图片

AccuBlator®Multi-channel Pulse Ablation Instrument and AccuPulse®7.5F Circular Pulse Ablation Catheter for use with,Compatible with most commercially available 3D mapping systems, short learning curve。Bipolar and biphasic pulse energy, with microsecond pulses rapidly released, makes the surgical process more efficient.The preferred energy formula can meet the needs of most patients undergoing treatment under local anesthesia.

Participating Institutions in This Clinical Trial

(Sorted by the initial letter)

The First Affiliated Hospital of Dalian Medical University

The Second Hospital of Hebei Medical University

Jiangsu Provincial People's Hospital

Tangdu Hospital, Air Force Medical University

Nanfang Hospital, Southern Medical University

West China Hospital of Sichuan University

The First Affiliated Hospital of Wenzhou Medical University

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University


# About AccuPulse

图片

As a startup deeply engaged in the field of electrophysiology, AccuPulse Medical Technology Co., Ltd. was established in November 2020. Focused on the cardiac electrophysiology sector, it is committed to providing patients with a one-stop solution for atrial fibrillation treatment. With the mission of "making atrial fibrillation surgery simple, effective, and safer," the company continuously drives technological innovation to serve more patients with atrial fibrillation, relentlessly pursuing its ideals!